R. Kontermann
发表
S. Dübel,
R. Kontermann,
2010,
Springer Berlin Heidelberg.
Kirstin A. Zettlitz,
R. Kontermann,
Jonas Hopp,
2010,
Protein engineering, design & selection : PEDS.
R. Kontermann,
2012
.
P. T. Jones,
P. Waterhouse,
W. Crosby,
1994,
The EMBO journal.
Roland Eils,
Florian Gantner,
Werner Rust,
2010,
PloS one.
R. Kontermann,
Nadine Aschmoneit,
Lennart Kühl,
2021,
Journal for ImmunoTherapy of Cancer.
R. Kontermann,
R. Fischer,
K. Pfizenmaier,
2020,
Frontiers in Cell and Developmental Biology.
R. Kontermann,
2005,
Acta Pharmacologica Sinica.
R. Kontermann,
O. Heidenreich,
D. Müller,
2010,
Journal of controlled release : official journal of the Controlled Release Society.
R. Kontermann,
D. Nettelbeck,
G. Ungerechts,
2021,
mAbs.
R. Kontermann,
Roland Kontermann,
2012,
mAbs.
R. Kontermann,
K. Ohlsen,
B. Zimmermann,
2014,
Human vaccines & immunotherapeutics.
P. Carter,
T. Wurch,
R. Kontermann,
2013,
mAbs.
T. Sauter,
P. Lucarelli,
R. Kontermann,
2018,
npj Systems Biology and Applications.
R. Kontermann,
K. Pfizenmaier,
F. Steiniger,
2014,
Bioconjugate chemistry.
R. Kontermann,
K. Pfizenmaier,
M. Siegemund,
2013,
Molecular Cancer Therapeutics.
R. Kontermann,
Dafne Müller and,
2014
.
R. Kontermann,
Nora Hornig,
D. Müller,
2013,
Cancer Immunology, Immunotherapy.
Q. Yuan,
M. Ott,
R. Kontermann,
2013,
Blood.
A. Herrmann,
P. Scheurich,
Kirstin A. Zettlitz,
2018,
mAbs.
M. Little,
F. Breitling,
S. Dübel,
1995,
Journal of immunological methods.
B. Schlosshauer,
R. Kontermann,
Liane Schuster,
2015,
Molecular pharmaceutics.
R. Kontermann,
2010,
Current opinion in molecular therapeutics.
R. Kontermann,
D. Müller,
A. Fahr,
2005,
Journal of drug targeting.
Monilola A. Olayioye,
R. Kontermann,
M. Schwab,
2022,
Molecular cancer therapeutics.
R. Kontermann,
M. Rothdiener,
Julia Beuttler,
2010,
Methods in molecular biology.
R. Kontermann,
K. Pfizenmaier,
M. Siegemund,
2017,
Front. Immunol..
H. Allgayer,
R. Kontermann,
D. Nettelbeck,
2015,
International journal of cancer.
U. Brinkmann,
R. Kontermann,
A. Bujotzek,
2019,
Antibodies.
R. Kontermann,
D. Müller,
Patrick Baum,
2007,
Journal of drug targeting.
I. Hilger,
R. Kontermann,
A. Fahr,
2018,
Biochimica et biophysica acta. General subjects.
R. Kontermann,
Shant Kumar,
Julia Smith,
2005,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
R. Kontermann,
R. Müller,
T. Völkel,
2004,
Biochemical and biophysical research communications.
R. Kontermann,
O. Seifert,
F. Richter,
2019,
mAbs.
R. Kontermann,
2011
.
R. Kontermann,
D. Müller,
Dafne Müller,
2011
.
R. Kontermann,
R. Müller,
T. Korn,
2004,
Journal of immunotherapy.
R. Kontermann,
R. Müller,
T. Völkel,
2001,
Protein engineering.
S. Dübel,
R. Kontermann,
I. Queitsch,
1994,
Analytical biochemistry.
A. Enk,
R. Kontermann,
D. Nettelbeck,
2008,
Clinical Cancer Research.
M. Manns,
F. Lehner,
T. Krech,
2013,
Hepatology.
R. Kontermann,
N. Fischer,
P. Malinge,
2016,
mAbs.
D. Jäger,
R. Kontermann,
G. Dyckhoff,
2014,
Protein engineering, design & selection : PEDS.
S. Canevari,
R. Kontermann,
A. Desideri,
2018,
mAbs.
G. Kollias,
H. Lassmann,
R. Kontermann,
2021,
Journal of neuroinflammation.
R. Kontermann,
2016,
Expert opinion on biological therapy.
R. Kontermann,
E. Bautz,
Michael Kobor,
1993,
Protein science : a publication of the Protein Society.
D. Jäger,
R. Kontermann,
G. Dyckhoff,
2013,
mAbs.
A. Herrmann,
R. Kontermann,
K. Pfizenmaier,
2019,
mAbs.
G. Kollias,
H. Lassmann,
R. Kontermann,
2021
.
R. Kontermann,
R. Fischer,
O. Maier,
2015
.
R. Kontermann,
D. Müller,
Sabrina Sapski,
2017,
Oncoimmunology.
R. Kontermann,
G. Winter,
M. Wing,
1997,
Nature Biotechnology.
R. Kontermann,
2004,
Methods.
R. Kontermann,
D. Müller,
Dafne Müller,
2010,
BioDrugs.
M. Wagner,
Kirstin A. Zettlitz,
R. Kontermann,
2011,
Journal of immunological methods.
R. Kontermann,
R. Fischer,
K. Pfizenmaier,
2019,
Front. Pharmacol..
A. Herrmann,
R. Kontermann,
R. Fischer,
2018,
Scientific Reports.
A. Herrmann,
R. Kontermann,
R. Fischer,
2018
.
R. Kontermann,
V. Jérôme,
R. Müller,
2006,
Journal of immunotherapy.
R. Kontermann,
E. Bautz,
Ekkehard K.F. Bautz,
1994,
FEBS letters.
R. Kontermann,
O. Seifert,
Meike Hutt,
2015,
PloS one.
U. Brinkmann,
I. Thorey,
R. Kontermann,
2018,
Biological chemistry.
A. Herrmann,
P. Scheurich,
Kirstin A. Zettlitz,
2013,
Protein engineering, design & selection : PEDS.
R. Kontermann,
M. Siegemund,
Nadine Aschmoneit,
2022,
Oncoimmunology.
R. Kontermann,
Nora Hornig,
A. Bondarieva,
2013,
Molecular Cancer Therapeutics.
R. Kontermann,
Nora Hornig,
A. Bondarieva,
2013
.
R. Kontermann,
Nora Hornig,
Vanessa Kermer,
2012,
Molecular Cancer Therapeutics.
K. Moxon,
R. Kontermann,
R. Fischer,
2019,
CNS neuroscience & therapeutics.
R. Kontermann,
D. Nettelbeck,
D. Nettelbeck,
1999,
British Journal of Cancer.
Monilola A. Olayioye,
R. Kontermann,
M. Olayioye,
2021,
mAbs.
R. Kontermann,
R. Müller,
H. Heidtmann,
2005,
Molecular biotechnology.
A. Herrmann,
R. Kontermann,
P. Naudé,
2016,
Proceedings of the National Academy of Sciences.
U. Brinkmann,
R. Kontermann,
2015,
Drug discovery today.
R. Kontermann,
M. Quintanilla,
A. Sichelstiel,
2008,
Journal of immunological methods.
R. Kontermann,
F. Frejd,
M. Rothdiener,
2009,
Bioconjugate chemistry.
R. Kontermann,
D. Nettelbeck,
R. Müller,
2004,
The journal of gene medicine.
R. Kontermann,
A. Nussler,
K. Pfizenmaier,
2012,
Cell Death and Disease.
M. Little,
F. Breitling,
S. Dübel,
1995,
Cell Biophysics.
R. Kontermann,
M. Hofmann,
S. Bunk,
2022,
Antibodies.
R. Kontermann,
Katharina Frey,
Dafne Müller,
2008,
Journal of immunotherapy.
R. Kontermann,
R. Deppisch,
E. Rauterberg,
1990,
European journal of immunology.
R. Kontermann,
2012,
BioDrugs.
R. Kontermann,
Roland E Kontermann,
2011,
Current opinion in biotechnology.
Ulrich Brinkmann,
U. Brinkmann,
R. Kontermann,
2017,
mAbs.
R. Kontermann,
G. Winter,
A. Griffiths,
1996,
Proceedings of the National Academy of Sciences of the United States of America.
J. Mora,
R. Kontermann,
A. Amaral,
2018,
Clinical Cancer Research.
R. Kontermann,
Katharina Mack,
O. Seifert,
2012
.
K. Landfester,
U. Şahin,
R. Kontermann,
2015,
Biomaterials.
R. Kontermann,
2012,
Archives of biochemistry and biophysics.
R. Kontermann,
G. Petersen,
S. W. Ng,
1992,
Biochimica et biophysica acta.
R. Kontermann,
H. Heidtmann,
1998,
Thrombosis research.
U. Brinkmann,
R. Kontermann,
2015
.
R. Kontermann,
R. Fischer,
K. Pfizenmaier,
2018,
Arthritis & rheumatology.
D. Mennerich,
R. Kontermann,
A. Weith,
2010,
Oligonucleotides.
R. Kontermann,
R. Fischer,
K. Pfizenmaier,
2017,
Scientific Reports.
R. Kontermann,
M. Siegemund,
J. Prassler,
2021,
Frontiers in Pharmacology.
R. Kontermann,
S. Montigiani,
R. Müller,
2003,
Oncogene.
M. Hidalgo,
R. Kontermann,
P. López-Casas,
2020,
Clinical Cancer Research.
R. Kontermann,
D. Nettelbeck,
A. Rivera,
2004,
International journal of cancer.
R. Kontermann,
F. Hanisch,
R. Stork,
2008,
Journal of Biological Chemistry.
Monilola A. Olayioye,
R. Kontermann,
C. Sers,
2016,
Oncotarget.
I. Hilger,
R. Kontermann,
A. Fahr,
2020,
Pharmaceutics.
R. Kontermann,
D. Nettelbeck,
D. Nettelbeck,
2001,
Molecular therapy : the journal of the American Society of Gene Therapy.
L. Pardo,
R. Kontermann,
K. Pfizenmaier,
2020,
Frontiers in Pharmacology.
R. Kontermann,
E. Rauterberg,
1989,
Molecular immunology.
R. Kontermann,
B. Meissburger,
Anette C. Karle,
2007,
Journal of Biological Chemistry.
A. Herrmann,
R. Kontermann,
R. Fischer,
2021,
Frontiers in Immunology.
C. Klein,
R. Kontermann,
A. Bujotzek,
2020,
mAbs.
I. Hilger,
R. Kontermann,
A. Fahr,
2020,
Pharmaceutics.
R. Kontermann,
A. Fahr,
F. Steiniger,
2015,
Journal of controlled release : official journal of the Controlled Release Society.
I. Hilger,
R. Kontermann,
A. Fahr,
2014,
Journal of controlled release : official journal of the Controlled Release Society.
K. Landfester,
P. Scheurich,
R. Kontermann,
2009,
Journal of controlled release : official journal of the Controlled Release Society.
C. Libert,
R. Kontermann,
M. Zenke,
2023,
Nature Immunology.
Sara Weirich,
R. Kontermann,
M. Rehm,
2021,
Molecules.
I. Hilger,
R. Kontermann,
A. Fahr,
2017,
BMC Biotechnology.
C. Praetorius,
R. Kontermann,
M. Rehm,
2020,
Cell Death & Differentiation.
R. Kontermann,
M. Olayioye,
Nadine Aschmoneit,
2020,
Molecular Cancer Therapeutics.
R. Kontermann,
M. Olayioye,
Nadine Aschmoneit,
2020
.
M. Manns,
R. Kontermann,
K. Schulze-Osthoff,
2020,
Cell Death & Disease.
T. Sauter,
A. Ginolhac,
R. Kontermann,
2022,
Cell death & disease.
R. Kontermann,
D. Ahmadvand,
M. Rasaee,
2009,
Molecular immunology.
F. Breitling,
S. Dübel,
R. Kontermann,
1995,
Biological chemistry Hoppe-Seyler.
R. Kontermann,
R. Müller,
Margitta Alt,
1999,
FEBS letters.
H. Monyer,
K. Keinänen,
R. Kontermann,
2010,
Nature Methods.
R. Kontermann,
Sarah Ring,
Nadine Beha,
2019,
Molecular Cancer Therapeutics.
R. Kontermann,
Nadine Aschmoneit,
Lennart Kühl,
2022,
mAbs.
M. Little,
F. Breitling,
S. Dübel,
1994,
Molecular immunology.
R. Kontermann,
R. Mueller,
Daniela Miller,
2000
.
R. Kontermann,
D. Nettelbeck,
Andrea Hesse,
2006,
Journal of Virology.
R. Kontermann,
B. Robert,
R. Stork,
2009,
The Journal of Biological Chemistry.
R. Kontermann,
Sabrina Sapski,
Nadine Beha,
2020,
Cancer Immunology, Immunotherapy.
R. Kontermann,
Nora Hornig,
Katharina Frey,
2012,
Journal of immunotherapy.
R. Kontermann,
Sarah Ring,
Sina Fellermeier,
2016,
Oncoimmunology.
U. Brinkmann,
R. Kontermann,
2018,
Drug discovery today.
R. Kontermann,
O. Seifert,
2022,
Molecules.
A. Herrmann,
R. Kontermann,
R. Fischer,
2018,
Scientific Reports.
Richard J Smeyne,
R. Kontermann,
R. Fischer,
2019,
Brain, Behavior, and Immunity.
Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity
A. Herrmann,
P. Scheurich,
R. Kontermann,
2013,
PloS one.
A. Herrmann,
P. Scheurich,
R. Kontermann,
2010,
mAbs.
Peter Scheurich,
Klaus Pfizenmaier,
P. Scheurich,
2009,
Expert opinion on drug discovery.
R. Kontermann,
Roland E Kontermann,
2006,
Current opinion in molecular therapeutics.
P. Carter,
T. Wurch,
R. Kontermann,
2013,
mAbs.
P. Carter,
T. Wurch,
R. Kontermann,
2022
.
R. Kontermann,
T. Merdan,
Peter Hölig,
2004,
Biochimica et biophysica acta.
C. Klein,
R. Kontermann,
A. Ducret,
2021,
The Journal of Immunology.
Michaela A. E. Arndt,
C. Körber,
N. Halama,
2015,
Cancer letters.
R. Kontermann,
Peter Hölig,
T. Völkel,
2004,
Protein engineering, design & selection : PEDS.
R. Kontermann,
K. Pfizenmaier,
M. Siegemund,
2018,
Scientific Reports.
R. Kontermann,
Nadine Aschmoneit,
Lennart Kühl,
2023,
mAbs.
Ingrid Hilger,
Alfred Fahr,
I. Hilger,
2016,
Biomaterials.
U. Şahin,
R. Kontermann,
K. Pfizenmaier,
2018,
Oncoimmunology.
R. Kontermann,
K. Pfizenmaier,
M. Siegemund,
2016,
mAbs.
R. Kontermann,
M. Siegemund,
O. Seifert,
2014,
Methods in molecular biology.
P. Scheurich,
R. Kontermann,
M. Rehm,
2020,
Cell Death & Differentiation.
M. Manns,
R. Kontermann,
K. Schulze-Osthoff,
2020,
Cell Death & Disease.
Monilola A. Olayioye,
R. Kontermann,
D. Delia,
2014,
PloS one.
R. Kontermann,
W. Seifarth,
E. Bautz,
1989,
Molecular and General Genetics MGG.
R. Kontermann,
Aline Färber-Schwarz,
F. Richter,
2012,
Protein engineering, design & selection : PEDS.
H. Klenk,
R. Kontermann,
H. Zeller,
2005,
Virology.
R. Kontermann,
Dafne Müller,
K. Zettlitz,
2010,
Molecular biotechnology.
R. Kontermann,
Roland Kontermann,
2012
.
Kathryn A. Swanson,
R. Kontermann,
R. Fischer,
2019,
Proceedings of the National Academy of Sciences.
P. Scheurich,
R. Kontermann,
K. Pfizenmaier,
2008,
Journal of immunotherapy.
F. Allgöwer,
R. Kontermann,
M. Rehm,
2018,
Cell Death & Disease.
R. Kontermann,
K. Pfizenmaier,
M. Siegemund,
2017,
Molecular Cancer Therapeutics.
R. Kontermann,
K. Pfizenmaier,
J. Laman,
2023,
Journal of Neuroinflammation.
R. Kontermann,
K. Pfizenmaier,
R. Diem,
2023,
Journal of Neuroinflammation.
R. Kontermann,
H. Wajant,
R. Fischer,
2014,
Glia.
R. Kontermann,
T. Völkel,
T. Korn,
2001
.
R. Kontermann,
Nadine Aschmoneit,
Lennart Kühl,
2021,
Scientific Reports.
R. Kontermann,
A. Dolga,
K. Pfizenmaier,
2023,
Scientific reports.
R. Kontermann,
Aline Färber-Schwarz,
F. Richter,
2011,
The Journal of Biological Chemistry.
R. Kontermann,
O. Seifert,
Aline Plappert,
2012,
Protein engineering, design & selection : PEDS.
U. Brinkmann,
R. Kontermann,
U. Weidle,
2014,
Seminars in oncology.
R. Kontermann,
R. Müller,
Roland E. Kontermann,
1999,
Journal of immunological methods.
Monilola A. Olayioye,
S. Dübel,
R. Kontermann,
2017,
mAbs.
R. Kontermann,
Dafne Müller and,
2008
.
I. Hilger,
R. Kontermann,
A. Fahr,
2017,
Acta biomaterialia.
R. Kontermann,
Dafne Müller,
2007,
Current opinion in molecular therapeutics.
R. Kontermann,
A. Kolbe,
J. Pleiss,
2008,
Bioconjugate chemistry.
R. Kontermann,
K. Pfizenmaier,
M. Siegemund,
2018,
Scientific Reports.
R. Kontermann,
Roland Stork,
Dafne Müller,
2007,
Protein engineering, design & selection : PEDS.
R. Kontermann,
A. Dietrich,
M. Siemann‐Herzberg,
2014,
Journal of biotechnology.
R. Kontermann,
C. Winter,
2001
.
R. Kontermann,
V. Jérôme,
T. Korn,
2003,
Methods in molecular biology.
R. Kontermann,
J. Huet,
W. Seifarth,
1991,
Molecular and General Genetics MGG.
R. Kontermann,
2011
.
R. Kontermann,
2012,
mAbs.
Michaela A. E. Arndt,
H. Allgayer,
R. Kontermann,
2015,
International journal of cancer.
R. Kontermann,
K. Pfizenmaier,
O. Seifert,
2018,
Oncotarget.
P. Scheurich,
R. Kontermann,
K. Pfizenmaier,
2008,
Journal of immunotherapy.
D. Allen,
P. Martineau,
R. Kontermann,
1997,
Immunotechnology : an international journal of immunological engineering.
G. Kollias,
H. Lassmann,
R. Kontermann,
2021,
Journal of Neuroinflammation.
U. Brinkmann,
R. Kontermann,
2021,
Science.
R. Kontermann,
F. Hanisch,
R. Stork,
2008,
Journal of Biological Chemistry.
J. Disselhorst,
R. Kontermann,
L. Quintanilla‐Martinez,
2023,
Nature Biomedical Engineering.
R. Kontermann,
Ulrich Brinkmann,
Christian Klein,
2024,
Nature reviews. Drug discovery.